{"Abstract": "The integration of artificial intelligence (AI) and machine learning (ML) into the drug discovery process has revolutionized lead-to-candidate decision-making, enhancing decision quality and efficiency. This study explores the application of AI and ML techniques in identifying promising drug candidates, focusing on their ability to process vast datasets and predict molecular properties with high accuracy. By leveraging computational toxicology, these technologies can assess potential toxicity and efficacy, thereby reducing the time and cost associated with traditional experimental methods. The research highlights key advancements in algorithm development and data integration, which have improved predictive modeling and facilitated the identification of novel compounds. Furthermore, the study discusses the challenges and future directions in the field, emphasizing the need for robust validation frameworks and interdisciplinary collaboration. Ultimately, AI and ML hold significant promise in transforming drug discovery, offering a pathway to more effective and safer therapeutics."}